Davie N - Search Results

1

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2).

Simonneau G, D'Armini AM, Ghofrani HA, Grimminger F, Hoeper MM, Jansa P, Kim NH, Wang C, Wilkins MR, Fritsch A, Davie N, Colorado P, Mayer E. Simonneau G, et al. Among authors: davie n. Eur Respir J. 2015 May;45(5):1293-302. doi: 10.1183/09031936.00087114. Epub 2014 Nov 13. Eur Respir J. 2015. PMID: 25395036 Free article. Clinical Trial.

2

Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2).

Rubin LJ, Galiè N, Grimminger F, Grünig E, Humbert M, Jing ZC, Keogh A, Langleben D, Fritsch A, Menezes F, Davie N, Ghofrani HA. Rubin LJ, et al. Among authors: davie n. Eur Respir J. 2015 May;45(5):1303-13. doi: 10.1183/09031936.00090614. Epub 2015 Jan 22. Eur Respir J. 2015. PMID: 25614164 Free article. Clinical Trial.

3

Use of responder threshold criteria to evaluate the response to treatment in the phase III CHEST-1 study.

D'Armini AM, Ghofrani HA, Kim NH, Mayer E, Morsolini M, Pulido-Zamudio T, Simonneau G, Wilkins MR, Curram J, Davie N, Hoeper MM. D'Armini AM, et al. Among authors: davie n. J Heart Lung Transplant. 2015 Mar;34(3):348-55. doi: 10.1016/j.healun.2015.02.003. Epub 2015 Feb 16. J Heart Lung Transplant. 2015. PMID: 25813765 Free article. Clinical Trial.

4

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.

Kim NH, D'Armini AM, Grimminger F, Grünig E, Hoeper MM, Jansa P, Mayer E, Neurohr C, Simonneau G, Torbicki A, Wang C, Fritsch A, Davie N, Ghofrani HA. Kim NH, et al. Among authors: davie n. Heart. 2017 Apr;103(8):599-606. doi: 10.1136/heartjnl-2016-309621. Epub 2016 Dec 23. Heart. 2017. PMID: 28011757 Free PMC article. Clinical Trial.

5

Comparison of hemodynamic parameters in treatment-naïve and pre-treated patients with pulmonary arterial hypertension in the randomized phase III PATENT-1 study.

Galiè N, Grimminger F, Grünig E, Hoeper MM, Humbert M, Jing ZC, Keogh AM, Langleben D, Rubin LJ, Fritsch A, Davie N, Ghofrani HA. Galiè N, et al. Among authors: davie n. J Heart Lung Transplant. 2017 May;36(5):509-519. doi: 10.1016/j.healun.2016.12.012. Epub 2016 Dec 24. J Heart Lung Transplant. 2017. PMID: 28190787 Free article. Clinical Trial.

6

Use of clinically relevant responder threshold criteria to evaluate the response to treatment in the phase III PATENT-1 study.

Langleben D, Galiè N, He J, Huang Y, Humbert M, Keogh A, Rubin LJ, Zhou D, Curram J, Davie N, Ghofrani HA. Langleben D, et al. Among authors: davie n. J Heart Lung Transplant. 2015 Mar;34(3):338-47. doi: 10.1016/j.healun.2014.12.001. Epub 2014 Dec 12. J Heart Lung Transplant. 2015. PMID: 25703961 Free article. Clinical Trial.

7

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension.

Kosanovic D, Kojonazarov B, Luitel H, Dahal BK, Sydykov A, Cornitescu T, Janssen W, Brandes RP, Davie N, Ghofrani HA, Weissmann N, Grimminger F, Seeger W, Schermuly RT. Kosanovic D, et al. Among authors: davie n. Respir Res. 2011 Jun 23;12:87. doi: 10.1186/1465-9921-12-87. Respir Res. 2011. PMID: 21699729 Free PMC article.

8

The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies.

Davie NJ, Schermuly RT, Weissmann N, Grimminger F, Ghofrani HA. Davie NJ, et al. Eur J Clin Invest. 2009 Jun;39 Suppl 2:38-49. doi: 10.1111/j.1365-2362.2009.02120.x. Eur J Clin Invest. 2009. PMID: 19335746 Review.

9

Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling.

Kojonazarov B, Sydykov A, Pullamsetti SS, Luitel H, Dahal BK, Kosanovic D, Tian X, Majewski M, Baumann C, Evans S, Phillips P, Fairman D, Davie N, Wayman C, Kilty I, Weissmann N, Grimminger F, Seeger W, Ghofrani HA, Schermuly RT. Kojonazarov B, et al. Among authors: davie n. Int J Cardiol. 2013 Sep 10;167(6):2630-7. doi: 10.1016/j.ijcard.2012.06.129. Epub 2012 Jul 31. Int J Cardiol. 2013. PMID: 22854298

10

Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment.

Hall SM, Davie N, Klein N, Haworth SG. Hall SM, et al. Among authors: davie n. Eur Respir J. 2011 Oct;38(4):851-60. doi: 10.1183/09031936.00167010. Epub 2011 Mar 15. Eur Respir J. 2011. PMID: 21406517 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page